Skip to main content

Table 1 Chikungunya vaccine candidates

From: Safety, immunogenicity, and effectiveness of chikungunya vaccines in pregnant persons, children, and adolescents: a protocol for a living systematic review and meta-analysis

Platform

Developer/manufacturer

Vaccine candidates

Live attenuated

Valneva Austria/Butantan Institute

VLA 1553 / IXCHIQ

181/clone 25 US Army Medical Research Institute of Infectious Disease, University of Maryland

TSI-GSD-218 (181/clone25)

Protein/subunit

Bavarian Nordic/NIH- PaxVax

PXVX0317

Emergent biosolutions

CHIKV VLP

National Institutes of Health Clinical Center (Bethesda, MD, USA)

VRC-CHKVLP059-00-VP

Inactivated

Bharat biotech/BBV87

BBV87/IVICHIK001

Vectored

Themis Bioscience GmbH

MV CHIK 202/206

National Institute of Allergy and Infectious Diseases (NIAID)/NIH

MV-CHIK

Oxford University

ChAdOx1 Chik (CHIK001)

Nucleic acid/mRNA

Moderna TX Inc

VAL-181388-P101

Others

mRNA-1944